BIOYF(BIOYF)
BIOYF
$11.40—Stale · unknown old
OTC • Last print unknown ago
$11.40—Stale · unknown old
No analyst ratings available
No analyst price targets available for BIOYF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $75M | $86M | $94M |
| Low | $75M | $86M | $94M |
| High | $75M | $86M | $94M |
| EBITDA Avg | $17M | $18M | $22M |
| Low | $17M | $18M | $22M |
| High | $17M | $18M | $22M |
| EBIT Avg | $15M | $16M | $20M |
| Low | $15M | $16M | $20M |
| High | $15M | $16M | $20M |
| Net Income Avg | $11M | $12M | $15M |
| Low | $11M | $12M | $15M |
| High | $11M | $12M | $15M |
| EPS Avg | $0.99 | $1.06 | $1.28 |
| Low | $0.99 | $1.06 | $1.28 |
| High | $0.99 | $1.06 | $1.28 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $20M | $20M |
| Low | $20M | $20M |
| High | $20M | $20M |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | — | — |
| Low | — | — |
| High | — | — |
| EPS Avg | — | — |
| Low | — | — |
| High | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — |